NAG-thiazoline is a strong competitive inhibitor of GH20 β-N-acetyl- hexosaminidases and GH84 β-N-acetylglucosaminidases. Here, we focused on the design, synthesis and inhibition potency of a series of new derivatives of NAG-thiazoline modified at the C-6 position. Dimerization of NAG-thiazoline via C-6 attached triazole linkers prepared by click chemistry was employed to make use of multivalency in the inhibition. Novel compounds were tested as potential inhibitors of β-N-acetylhexosaminidases from Talaromyces flavus, Streptomyces plicatus (both GH20) and β-N-acetylglucosaminidases from Bacteroides thetaiotaomicron and humans (both GH84). From the set of newly prepared NAG-thiazoline derivatives, only C-6-azido-NAG-thiazoline displayed inhibition activity towards these enzymes; C-6 triazole-substituted NAG-thiazolines lacked inhibition activity against the enzymes used. Docking of C-6-azido-NAG-thiazoline into the active site of the tested enzymes was performed. Moreover, a stability study with GlcNAc-thiazoline confirmed its decomposition at pH < 6 yielding 2-acetamido-2-deoxy-1-thio-α/β-D-glucopyranoses, which presumably dimerize oxidatively into S-S linked dimers; decomposition products of NAG-thiazoline are void of inhibitory activity.

Department of Structure and Function of Proteins Institute of Nanobiology and Structural Biology of GCRC Academy of Sciences of the Czech Republic Zámek 136 37333 Nové Hrady Czech Republic

Institute of Microbiology Academy of Sciences of the Czech Republic Vídeňská 1083 14220 Praha 4 Czech Republic

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic Flemingovo nám 2 16610 Praha 6 Czech Republic

Zobrazit více v PubMed

Knapp S., Vocadlo D., Gao Z., Kirk B., Lou J., Withers S.G. NAG-Thiazoline, an N-acetyl-β-hexosaminidase inhibitor that implicates acetamido participation. J. Am. Chem. Soc. 1996;118:6804–6805. doi: 10.1021/ja960826u. DOI

Slámová K., Bojarová P., Petrásková L., Křen V. β-N-Acetylhexosaminidase: What’s in a name…? Biotechnol. Adv. 2010;28:682–693. doi: 10.1016/j.biotechadv.2010.04.004. PubMed DOI

Yuzwa S.A., Macauley M.S., Heinonen J.E., Shan X., Dennis R.J., He Y., Whitworth G.E., Stubbs K.A., McEachern E.J., Davies G.J., et al. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 2008;4:483–490. doi: 10.1038/nchembio.96. PubMed DOI

Mahuran D.J. Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim. Biophys. Acta. 1999;1455:105–138. PubMed

Macauley M.S., Whitworth G.E., Debowski A.W., Chin D., Vocadlo D.J. O-GlcNAcase uses substrate-assisted catalysis: Kinetic analysis and development of highly selective mechanism-inspired inhibitors. J. Biol. Chem. 2005;280:25313–25322. doi: 10.1074/jbc.M413819200. PubMed DOI

Knapp S., Abdo M., Ajayi K., Huhn R.A., Emge T.J., Kim E.J., Hanover J.A. Tautomeric modification of GlcNAc-thiazoline. Org. Lett. 2007;9:2321–2324. doi: 10.1021/ol0706814. PubMed DOI

Amorelli B., Yang C., Rempel B., Withers S.G., Knapp S. N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines. Bioorg. Med. Chem. Lett. 2008;18:2944–2947. doi: 10.1016/j.bmcl.2008.03.067. PubMed DOI

Krejzová J., Šimon P., Vavříková E., Slámová K., Pelantová H., Riva S., Spiwok V., Křen V. Enzymatic synthesis of new C-6-acylated derivatives of NAG-thiazoline and evaluation of their inhibitor activities towards fungal β-N-acetylhexosaminidase. J. Mol. Catal. B-Enzym. 2013;87:128–134. doi: 10.1016/j.molcatb.2012.10.016. DOI

Yuzwa S.A., Shan X., Maculey M.S., Clark T., Skorobogatko Y., Vosseller K., Vocadlo D. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. J. Nat. Chem. Biol. 2012;8:393–399. doi: 10.1038/nchembio.797. PubMed DOI

Vocadlo D., McEachern E.W.O. Selective Glycosidase Inhibitors and Uses Thereof. Patent 2008/025170 A1. 2008 Mar 6;

Fialová P., Weignerová L., Rauvolfová J., Přikrylová V., Pišvejcová A., Ettrich R., Kuzma M., Sedmera P., Křen V. Hydrolytic and transglycosylation reactions of N-acyl modified substrates catalysed by β-N-acetylhexosaminidases. Tetrahedron. 2004;60:693–701. doi: 10.1016/j.tet.2003.10.111. DOI

Slámová K., Bojarová P., Gerstorferová D., Fliedrová B., Hofmeisterová J., Fiala M., Pompach P., Křen V. Sequencing, cloning and high-yield expression of a fungal β-N-acetylhexosaminidase in Pichia pastoris. Protein Expr. Purif. 2012;82:212–217. doi: 10.1016/j.pep.2012.01.004. PubMed DOI

Mark B.L., Vocadlo D.J., Knapp S., Triggs-Raine B.L., Withers S.G., James M.N.G. Crystallographic evidence for substrate-assisted catalysis in a bacterial β-hexosaminidase. J. Biol. Chem. 2001;276:10330–10337. PubMed

Gaussian 03. Gaussian, Inc.; Wallingford, CT, USA: 2004. Revision C.02.

Wang J., Wang W., Kollmann P., Case D. Antechamber, an accessory software package for molecular mechanical calculation. J. Comput. Chem. 2005;25:1157–1174.

Tews I., Perrakis A., Oppenheim A., Dauter Z., Wilson K.S., Vorgias C.E. Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease. Nat. Struct. Biol. 1996;3:638–648. doi: 10.1038/nsb0796-638. PubMed DOI

Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785–2791. doi: 10.1002/jcc.21256. PubMed DOI PMC

Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 1998;19:1639–1662. doi: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B. DOI

Dennis R.J., Taylor E.J., Macauley M.S., Stubbs K.A., Turkenburg J.P., Hart S.J., Black G.N., Vocadlo D.J., Davies G.J. Structure and mechanism of a bacterial β-glucosaminidase having O-GlcNAcase activity. Nat. Struct. Mol. Biol. 2006;13:365–371. doi: 10.1038/nsmb1079. PubMed DOI

Slámová K., Kulik N., Fiala M., Krejzová-Hofmeisterová J., Ettrich R., Křen V. Expression, characterization and homology modelling of a novel eukaryotic GH84 β-N-acetylglucosaminidase fom Penicillium chrysogenum. Protein Expr. Purif. 2014;95:204–210. doi: 10.1016/j.pep.2014.01.002. PubMed DOI

Krieger E., Joo K., Lee J., Raman S., Thompson J., Tyka M., Baker D., Karplus K. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins. 2009;77:114–122. doi: 10.1002/prot.22570. PubMed DOI PMC

Essman U., Perera L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103:8577–8593. doi: 10.1063/1.470117. DOI

Laskowski R.A., Swindells M.B. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 2011;51:2778–2786. doi: 10.1021/ci200227u. PubMed DOI

Mutation Hotspot for Changing the Substrate Specificity of β-N-Acetylhexosaminidase: A Library of GlcNAcases